PharmTech Drug Digest 11.20
News|Articles|December 2, 2018

Pharmaceutical Technology

  • Pharmaceutical Technology-12-02-2018
  • Volume 42
  • Issue 12

Sterile, Integrated Hood and Mask for Larger Heads and Hairstyles

Kimberly-Clark Professional added the Kimtech A5 Sterile Integrated Hood and Mask XL for head shapes, sizes, and hairstyles that pose a challenge to standard aseptic gowning for cleanroom operators.

Kimberly-Clark Professional added the Kimtech A5 Sterile Integrated Hood and Mask XL for head shapes, sizes, and hairstyles that pose a challenge to standard aseptic gowning for cleanroom operators.

The new gowning size combines two donning steps (hood and mask) into one, simplifying the donning process and further reducing the risk of contamination. This sterile product features a stretch-fit elastic hood and opening, tunneled overseams to prevent particle shedding, and Clean-Don Technology ties for a more secure fit. Additionally, the company says it provides free fittings. 

The company also reports that the hood and mask can be diverted from landfills through The RightCycle Program, a large-scale recycling program for non-hazardous lab, cleanroom, and industrial waste. The program turns used apparel, gloves, and protective eyewear into new consumer goods.

Source: Kimberly-Clark Professional


Related to this article

Are Your Supplier Selection and Oversight Processes Robust Enough?
Despite best efforts to ensure a contract organization is following GMPs, a warning letter is issued by the FDA. Susan J. Schniepp, distinguished fellow at Nelson Labs, and Siegfried Schmitt, PhD, vice president, Technical at Parexel, provide advice for create a robust supplier selection and oversight system.
white pill capsule isolated on white background | Image Credit: ©F16-ISO100 -stock.adobe.com
PharmTech spoke with Chiara Bergerone, deputy CEO of Roquette’s Health & Pharma Solutions Business, about the company’s hydroxypropyl methylcellulose (HPMC) capsule, which was previewed at CPHI Milan 2026 in October.
Transitioning mRNA from R&D to GMP
Marco Pupo, PhD, innovation and development coordinator at Anemocyte, discusses the R&D-to-GMP transition and the changing shape of mRNA manufacturing facilities.